American Well Co. (NYSE:AMWL – Get Rating) has been assigned a consensus rating of “Hold” from the ten brokerages that are currently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $8.50.
A number of equities research analysts have recently issued reports on the company. Truist Financial started coverage on American Well in a research note on Wednesday, September 7th. They set a “hold” rating and a $5.00 price objective on the stock. Piper Sandler lowered their price target on American Well from $6.00 to $5.00 in a report on Wednesday, September 7th.
Insider Activity at American Well
In other news, CEO Ido Schoenberg sold 136,472 shares of the company’s stock in a transaction dated Tuesday, June 21st. The shares were sold at an average price of $4.61, for a total transaction of $629,135.92. Following the sale, the chief executive officer now directly owns 2,373,108 shares in the company, valued at approximately $10,940,027.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Ido Schoenberg sold 136,472 shares of the business’s stock in a transaction that occurred on Tuesday, June 21st. The stock was sold at an average price of $4.61, for a total value of $629,135.92. Following the completion of the sale, the chief executive officer now owns 2,373,108 shares in the company, valued at $10,940,027.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Kurt Knight sold 25,151 shares of the company’s stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $4.37, for a total transaction of $109,909.87. Following the completion of the sale, the chief operating officer now directly owns 1,454,773 shares of the company’s stock, valued at approximately $6,357,358.01. The disclosure for this sale can be found here. In the last ninety days, insiders sold 522,904 shares of company stock worth $2,324,802. 13.91% of the stock is owned by company insiders.
Hedge Funds Weigh In On American Well
Ad Legacy Research
The One Ticker Retirement Plan – Over the Shoulder Demo Now Available
Market Wizard Larry Benedict crushed the market in 2022. But he hasn’t done it with a “traditional” method…
For a limited time, he’s sharing a free over-the-shoulder “demo” of his strategy in action. It takes less than 10 seconds…
Watch it here.
Several institutional investors and hedge funds have recently modified their holdings of the stock. Nisa Investment Advisors LLC increased its holdings in shares of American Well by 440.0% during the 1st quarter. Nisa Investment Advisors LLC now owns 8,100 shares of the company’s stock worth $34,000 after buying an additional 6,600 shares during the last quarter. Point72 Hong Kong Ltd lifted its holdings in American Well by 175.1% during the 1st quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company’s stock worth $34,000 after buying an additional 5,147 shares during the last quarter. Vigilant Capital Management LLC acquired a new stake in American Well during the 1st quarter worth $42,000. US Bancorp DE lifted its stake in American Well by 605.2% in the second quarter. US Bancorp DE now owns 9,556 shares of the company’s stock valued at $42,000 after buying an additional 8,201 shares during the last quarter. Finally, Mackenzie Financial Corp purchased a new stake in shares of American Well during the first quarter worth approximately $43,000. Institutional investors and hedge funds own 46.62% of the company’s stock.
American Well Price Performance
Shares of AMWL opened at $4.33 on Monday. The company has a market capitalization of $1.18 billion, a PE ratio of -4.87 and a beta of -0.06. The company’s fifty day moving average price is $4.55 and its 200 day moving average price is $4.04. American Well has a one year low of $2.52 and a one year high of $11.40.
American Well (NYSE:AMWL – Get Rating) last issued its earnings results on Thursday, August 4th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.01. The business had revenue of $64.52 million for the quarter, compared to analyst estimates of $64.13 million. American Well had a negative net margin of 90.47% and a negative return on equity of 19.36%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business earned ($0.15) EPS. Analysts anticipate that American Well will post -0.99 earnings per share for the current year.
American Well Company Profile
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider American Well, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and American Well wasn’t on the list.
While American Well currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
